Thermo Fisher Scientific Inc (NYSE: TMO), a company involved in serving science, announced on Tuesday that it has named Paul G Parker as its new senior vice president, strategy and corporate development effective 15 April 2020.
Parker will report to Marc N Casper, chairman, president and chief executive officer, and will be based in Waltham, Massachusetts.
Parker joins from Goldman Sachs & Co, where he served for six years as co-chairman of Global Mergers & Acquisitions and as a member of the firm's Partnership Committee. His investment banking career covers 35 years, having held various global operating and senior client relationship roles at Goldman Sachs and other financial services firms including Barclays, Lehman Brothers and JP Morgan. Parker is a graduate of Harvard Business School and The University of North Carolina at Chapel Hill.
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head
DELFI Diagnostics CTO receives 2025 Most Influential Women in Bay Area Business recognition
Clario acquires imaging provider NeuroRx
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
iOncologi acquires TargImmune Therapeutics
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval